Why are my TSH and free T4 both low while I am on levothyroxine (Synthroid) therapy?

Low TSH and Low T4 on Levothyroxine Treatment

This pattern of both low TSH and low free T4 while on levothyroxine strongly suggests central (secondary) hypothyroidism, medication non-adherence, or a critical timing issue with blood draw relative to medication intake—not typical primary hypothyroidism on treatment.

Understanding the Abnormal Pattern

In primary hypothyroidism being treated with levothyroxine, you would expect:

• Normal or elevated TSH if underdosed
• Low TSH with normal/high free T4 if adequately dosed or overdosed

The combination of low TSH AND low free T4 is distinctly abnormal and requires immediate investigation.

Most Likely Causes

1. Central (Secondary) Hypothyroidism

If you have central hypothyroidism rather than primary hypothyroidism, TSH cannot be used to guide therapy 1. In central hypothyroidism:

• The pituitary fails to produce adequate TSH
• Free T4 levels (not TSH) must guide dosing
• Target free T4 should be above the mean of the reference range 1
• Dosing is typically estimated at 1.6 μg/kg daily 1

Critical pitfall: Patients with central hypothyroidism may have adrenal insufficiency, which must be treated with hydrocortisone before or concurrent with levothyroxine to avoid precipitating adrenal crisis 1, 2.

2. Medication Non-Adherence

This is the most common cause when patients on high doses (>200 μg/day) have persistently abnormal TSH levels 1. With sporadic dosing:

• TSH may be suppressed from recent doses
• Free T4 remains low from overall inadequate intake
• Consider supervised weekly dosing if compliance is problematic 1

3. Blood Draw Timing Error

If blood was drawn shortly after taking levothyroxine:

• Free T4 may appear falsely low if measured during the absorption phase
• Blood should be drawn before taking the daily dose 1
• Wait 4-8 weeks after any dose adjustment before retesting 1

4. Critical Illness or Medications

Several conditions can cause this pattern 1:

• Acute severe illness: TSH may be suppressed below 0.1 mIU/L with subnormal free T4 in critically ill patients
• Dopamine infusions or high-dose glucocorticoids suppress TSH 1
• Recovery phase from nonthyroidal illness: Can transiently alter both values 1

Immediate Diagnostic Steps

1. Verify the diagnosis: Review whether primary vs. central hypothyroidism was established

   • Check for history of pituitary/hypothalamic disease
   • Review initial diagnostic labs before treatment started

2. Assess medication adherence:

   • Direct questioning about missed doses
   • Consider levothyroxine absorption test if malabsorption suspected 3

3. Check for interfering factors 2:

   • Medications affecting absorption (calcium, iron, PPIs, bile acid sequestrants)
   • Medications affecting metabolism (amiodarone, beta-blockers >160mg/day, glucocorticoids)
   • Take levothyroxine 30-60 minutes before breakfast on empty stomach 1

4. Rule out adrenal insufficiency:

   • Particularly important if central hypothyroidism is present
   • Elevated TSH with normal T4 can occur with adrenal insufficiency and normalize with glucocorticoid therapy alone 1

Management Algorithm

If central hypothyroidism is confirmed:

• Disregard TSH completely for dosing decisions 1
• Dose based on free T4 levels, targeting above the mean reference range
• Screen and treat adrenal insufficiency first 1, 2

If primary hypothyroidism with adherence issues:

• Consider supervised weekly dosing (7x daily dose once weekly) 1
• Recheck TSH and free T4 in 4-8 weeks 1

If absorption problems suspected:

• Separate levothyroxine from interfering medications by at least 4 hours 2
• Consider levothyroxine absorption test (10 μg/kg or max 600 μg): free T4 increment >0.40 ng/dL at 3 hours excludes true malabsorption 3

If timing error:

• Repeat labs before morning dose
• Ensure 4-8 weeks have passed since last dose change 1

Key Monitoring Points

• In treated primary hypothyroidism, TSH is the most reliable endpoint 1
• Target TSH within normal reference range (0.4-4.12 mIU/L) 1
• Recent research shows treated patients typically have higher free T4 and lower TSH than untreated euthyroid individuals 4, 5, 6
• The free T3:free T4 ratio is approximately 15-20% lower in levothyroxine-treated patients 7

This unusual pattern demands investigation—it is not a typical response to levothyroxine therapy and suggests either wrong diagnosis, non-adherence, or significant confounding factors.